Nutriband (NTRB) to Release Quarterly Earnings on Tuesday

Nutriband (NASDAQ:NTRBGet Free Report) is expected to release its results before the market opens on Tuesday, September 2nd. Analysts expect Nutriband to post earnings of ($0.17) per share and revenue of $0.7050 million for the quarter.

Nutriband (NASDAQ:NTRBGet Free Report) last released its earnings results on Friday, May 30th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.01. The company had revenue of $0.67 million during the quarter, compared to analyst estimates of $0.71 million. Nutriband had a negative return on equity of 68.25% and a negative net margin of 415.93%. On average, analysts expect Nutriband to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nutriband Stock Performance

NTRB stock opened at $6.41 on Tuesday. The firm has a market cap of $71.47 million, a PE ratio of -7.12 and a beta of 1.13. The company has a quick ratio of 3.48, a current ratio of 3.71 and a debt-to-equity ratio of 0.01. The business has a 50 day moving average of $7.68 and a 200-day moving average of $6.78. Nutriband has a 12-month low of $3.72 and a 12-month high of $11.78.

About Nutriband

(Get Free Report)

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.

Featured Articles

Earnings History for Nutriband (NASDAQ:NTRB)

Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.